share_log

Surgalign Receives FDA Clearance For HOLO Portal System, The World's First AI-driven AR Guidance System For Spine Surgery

Benzinga Real-time News ·  Jan 18, 2022 04:32

Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has received U.S. Food & Drug Administration (FDA) 510(k) clearance for its HOLO Portal surgical guidance system for use within lumbar spine procedures. The HOLO Portal system is the world's first artificial intelligence (AI)-driven augmented reality (AR) guidance system for spine and the first clinical application of Surgalign's HOLOTM AI digital health platform.

"Receiving the initial clearance for the HOLO Portal system is a significant milestone and represents a...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment